Eric J. Hyllengren
Chief Financial Officer · Tenaya Therapeutics, Inc.
- 2024
- Jul 15, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eric J. Hyllengren files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AI Biotechnology LLC - $12.50M in ZURA purchases and sales in the last 12 months
- COLUMN GROUP III GP, LP - $5.93M in TNYA purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $4.74M in ATRA purchases and sales in the last 12 months
- Panacea Innovation Ltd - $3.65M in ATRA purchases and sales in the last 12 months
- Brian N. Cherry - $1000K in ATRA purchases and sales in the last 12 months
- Anhco Nguyen - $142K in ATRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric J. Hyllengren?
Eric J. Hyllengren is a corporate insider, tracked as Chief Financial Officer of Tenaya Therapeutics, Inc. (TNYA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eric J. Hyllengren last file a Form 4?
The most recent primary Form 4 on record is dated 15 July 2026, one of 4 filings going back to 2024.
Has Eric J. Hyllengren been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($15K) across all tracked filings.
